DecisionDx-Melanoma is a prognostic test for patients diagnosed with Stage I – III cutaneous melanoma. Our test looks at your tumor biology to predict the risk of your melanoma spreading or coming back.
Download the patient discussion guide to facilitate a conversation with your healthcare to determine if DecisionDx-Melanoma is right for you.
Be your own advocate: Morgan England, stage III melanoma survivor, shares her story
With DecisionDx-Melanoma, you and your doctor can make informed decisions about:
Treatment
Follow-up appointments with your dermatologist
Additional visits with other specialties (referrals)
Surgical procedures such as a sentinel lymph node biopsy
Hear how physicians use DecisionDx-Melanoma
Why DecisionDx-Melanoma?
Talk to your doctor to determine if the DecisionDx-Melanoma test is right for you.
References
- Berger et al. CMRO. 2016.
- Farberg et al. J Drugs Derm. 2017.
- Dillon et al. CMRO. 2022.
- Bailey et al. JCO PO. 2023.
- Dhillon et al. Arch Dermatol Res. 2023.